Clinical Outcome of Defect Reconstruction Using IDRT Single Layer : Results From a Prospective Multicentric Trial

• Age ≥ 18 years
• Patient with 1 traumatic wound (burns included) or 1 reconstruction wound (oncological wounds included)
• Patients for whom the surgeon has recommended that an INTEGRA® SL matrix be implanted (even if the patient is not taking part in the study) with a Split Thickness Skin Graft in the same operating procedure
• Wound treated with only one layer of a maximum size 10cm*12.5cm

Exclusion Criteria:

• Immunosuppressed patient
• Chronic wound (with no healing since 6 months)
• Addition of any substances (growth factor, stem cells,...) in the IDRT SL during the surgery
• Patient with a corticoid treatment with a daily dose greater than 5 mg
• Patients whose life expectancy is less than 12 months
• Patients whose mental health or health condition (Visual deficiency, Alzheimers...) would compromise completion of the self-evaluation questionnaires
• Patient with an hypersensitivity to bovine collagen, chondroitin
• Patient with clinical signs of infection (fever, pain, colour, swelling,...) and for whom the investigator diagnosed infection